[Blood flow insufficiency in vertebrobasilar system].
Ethiopathological and clinical factors of vertebral blood flow insufficiency development are discussed in the article. Distinct connection between pathogenesis and stages of clinical manifestation is proved and nosological independence of vertebrobasilar disease is validated. Used in combined therapy of patients with the disease, cavinton is shown to exert a positive effect on the main clinical symptoms.
Sitel'
A B
AB
Teterina
E B
EB
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000098:blood supply* / Q000473:pathology; D004833:Epilepsy, Temporal Lobe / Q000209:etiology; D005260:Female; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D014665:Vasodilator Agents / Q000627:therapeutic use; D014715:Vertebrobasilar Insufficiency / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000927:Anticonvulsants; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine